Details for Patent: 11,021,475
✉ Email this page to a colleague
Which drugs does patent 11,021,475 protect, and when does it expire?
Patent 11,021,475 protects SOTYKTU and is included in one NDA.
This patent has sixty-three patent family members in thirty-six countries.
Drugs Protected by US Patent 11,021,475
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | SOTYKTU | deucravacitinib | TABLET;ORAL | 214958-001 | Sep 9, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN ADULTS WHO ARE CANDIDATES FOR SYSTEMIC THERAPY OR PHOTOTHERAPY | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,021,475
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 094452 | ⤷ Try a Trial | |||
Australia | 2013341186 | ⤷ Try a Trial | |||
Australia | 2017201076 | ⤷ Try a Trial | |||
Australia | 2018267545 | ⤷ Try a Trial | |||
Australia | 2020203967 | ⤷ Try a Trial | |||
Brazil | 112015010102 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |